NCT03367195 - Efficacy and Safety of DLBS2411 in the Management of GERD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 16, 2018

Primary Completion Date

May 4, 2020

Study Completion Date

September 9, 2020

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DRUG

Omeprazole

1 Omeprazole 20 mg capsules twice daily

DRUG

DLBS2411

1 DLBS2411 caplet 250 mg, twice daily

DRUG

Placebo capsule of Omeprazole

1 placebo capsule of omeprazole, twice daily

DRUG

Placebo caplet of DLBS2411

1 placebo caplet of DLBS2411, twice daily

Trial Locations (5)

10430

Division of Gastroenterology Department of Internal Medicine Faculty of Medicine, University of Indonesia Dr. Cipto Mangunkusumo National General Hospital, Jakarta

Unknown

Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Padjajaran Dr. Hasan Sadikin Hospital, Bandung

Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Diponegoro Dr. Kariadi Hospital, Semarang

Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Airlangga Dr. Soetomo Hospital, Surabaya

Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Gadjah Mada Dr. Sardjito Hospital, Yogyakarta